Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Harlow John B. Jr. — Esperion Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Harlow John B. Jr.

Harlow John B. Jr.

Chief Commercial Officer at Esperion Therapeutics, Inc. · on record since Nov 17, 2025

Insider trading activity of Harlow John B. Jr.

Transactions on record: 2; since Dec 8, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Dec 8, 2025

Figures computed from official regulatory filings — methodology.

Companies where Harlow John B. Jr. has traded

Esperion Therapeutics, Inc.2 tx · Dec 8, 2025

Track record of Harlow John B. Jr.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Harlow John B. Jr.

Co-insiders of Harlow John B. Jr.

Aisling Capital II LPEsperion Therapeutics, Inc.
AISLING CAPITAL PARTNERS LLCEsperion Therapeutics, Inc.
AISLING CAPITAL PARTNERS, LPEsperion Therapeutics, Inc.
Alta Partners Management VIII, LLCEsperion Therapeutics, Inc.
Alta Partners VIII, L.P.Esperion Therapeutics, Inc.
Bartram RichardEsperion Therapeutics, Inc.
BAYH SUSAN BEsperion Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BB BIOTECH AGEsperion Therapeutics, Inc.

Berkowitz JeffreyEsperion Therapeutics, Inc.

BIOTECH TARGET N VEsperion Therapeutics, Inc.

BLAIR HENRY EEsperion Therapeutics, Inc.

BLAIR JAMES CEsperion Therapeutics, Inc.

Boxer Asset Management Inc.Esperion Therapeutics, Inc.

Boxer Capital, LLCEsperion Therapeutics, Inc.

Braslyn Ltd.Esperion Therapeutics, Inc.

Braunstein ScottEsperion Therapeutics, Inc.

BRINKERHOFF WILLIAM FEsperion Therapeutics, Inc.

CARROLL J MARTINEsperion Therapeutics, Inc.

CHAMPSI FARAHEsperion Therapeutics, Inc.

CRESSWELL RONALD MEsperion Therapeutics, Inc.

DASSEUX JEAN LOUIS HEsperion Therapeutics, Inc.

DOMAIN ASSOCIATESEsperion Therapeutics, Inc.

DOMAIN PARTERS VII L PEsperion Therapeutics, Inc.

DOVEY BRIAN HEsperion Therapeutics, Inc.

DP VII ASSOCIATES LPEsperion Therapeutics, Inc.

DURUS CAPITAL MANAGEMENTEsperion Therapeutics, Inc.

DURUS CAPITAL MANAGEMENT NA LLCEsperion Therapeutics, Inc.

DURUS LIFE SCIENCES MASTER FUND LTDEsperion Therapeutics, Inc.

ELMS STEVEEsperion Therapeutics, Inc.

ENRIGHT PATRICK GEsperion Therapeutics, Inc.

Fischer Seth H.Z.Esperion Therapeutics, Inc.

Foody Joanne M.Esperion Therapeutics, Inc.

Fuhrman AlanEsperion Therapeutics, Inc.

Glickman Mark AEsperion Therapeutics, Inc.

GOLDSTEIN DOV A MDEsperion Therapeutics, Inc.

GOTTO ANTONIO M JREsperion Therapeutics, Inc.

GOTTO ANTONIO M JR MD D PHILEsperion Therapeutics, Inc.

Halak Brian KEsperion Therapeutics, Inc.

Halladay BenjaminEsperion Therapeutics, Inc.

Hall AshleyEsperion Therapeutics, Inc.

HOFFMAN ROBERTEsperion Therapeutics, Inc.

Ignelzi Troy A.Esperion Therapeutics, Inc.

JANNEY DANIELEsperion Therapeutics, Inc.

Kamdar Kim P.Esperion Therapeutics, Inc.

Koenig Sheldon L.Esperion Therapeutics, Inc.

KRAUSE BRIAN REsperion Therapeutics, Inc.

Lalwani Narendra D.Esperion Therapeutics, Inc.

LANGE LOUIS GEsperion Therapeutics, Inc.

LEWIS JOSEPHEsperion Therapeutics, Inc.

Longitude Capital Associates, L.P.Esperion Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Esperion Therapeutics, Inc.	Dec 8, 2025	AwardD	380,000	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Dec 8, 2025	Award	424,536	0.00 USD	$0	SEC